NL6614961A - - Google Patents

Info

Publication number
NL6614961A
NL6614961A NL6614961A NL6614961A NL6614961A NL 6614961 A NL6614961 A NL 6614961A NL 6614961 A NL6614961 A NL 6614961A NL 6614961 A NL6614961 A NL 6614961A NL 6614961 A NL6614961 A NL 6614961A
Authority
NL
Netherlands
Application number
NL6614961A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of NL6614961A publication Critical patent/NL6614961A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/50Three nitrogen atoms
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
NL6614961A 1965-10-22 1966-10-21 NL6614961A (US07223432-20070529-C00017.png)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
CH1463065A CH478816A (de) 1965-10-22 1965-10-22 Verfahren zur Herstellung neuer N,N'-Di-(pyrimidyl-(4)-aminoalkyl)-diazacycloalkanen
CH1751468A CH499528A (de) 1965-10-22 1965-10-22 Verfahren zur Herstellung neuer Pyrimidine
CH506568A CH478819A (de) 1965-10-22 1965-10-22 Verfahren zur Herstellung neuer N,N'-Di-(pyrimidyl-(4)-aminoalkyl)-diazacycloalkanen
CH506468A CH478818A (de) 1965-10-22 1965-10-22 Verfahren zur Herstellung neuer N,N'-Di-(pyrimidyl-(4)-aminoalkyl)-diazacycloalkanen
CH506368A CH478817A (de) 1965-10-22 1965-10-22 Verfahren zur Herstellung neuer N,N'-Di-(pyrimidyl-(4)-aminoalkyl)-diazacycloalkanen
CH1133066 1966-08-05

Publications (1)

Publication Number Publication Date
NL6614961A true NL6614961A (US07223432-20070529-C00017.png) 1967-04-24

Family

ID=27543760

Family Applications (1)

Application Number Title Priority Date Filing Date
NL6614961A NL6614961A (US07223432-20070529-C00017.png) 1965-10-22 1966-10-21

Country Status (11)

Country Link
US (1) US3503963A (US07223432-20070529-C00017.png)
BE (1) BE688660A (US07223432-20070529-C00017.png)
BR (1) BR6683919D0 (US07223432-20070529-C00017.png)
CH (5) CH478819A (US07223432-20070529-C00017.png)
DE (1) DE1670392A1 (US07223432-20070529-C00017.png)
FR (3) FR1500479A (US07223432-20070529-C00017.png)
GB (1) GB1135259A (US07223432-20070529-C00017.png)
IL (1) IL26473A (US07223432-20070529-C00017.png)
NL (1) NL6614961A (US07223432-20070529-C00017.png)
SE (1) SE345273B (US07223432-20070529-C00017.png)
SU (2) SU427513A3 (US07223432-20070529-C00017.png)

Cited By (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7470699B2 (en) 2003-07-11 2008-12-30 Arena Pharmaceuticals, Inc. Trisubstituted aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto
US7812159B2 (en) 2005-01-10 2010-10-12 Arena Pharamaceuticals, Inc. Processes for preparing aromatic ethers
US8293751B2 (en) 2003-01-14 2012-10-23 Arena Pharmaceuticals, Inc. 1,2,3-trisubstituted aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto such as diabetes and hyperglycemia
US8362248B2 (en) 2005-01-10 2013-01-29 Arena Pharmaceuticals, Inc. Substituted pyridinyl and pyrimidinyl derivatives as modulators of metabolism and the treatment of disorders related thereto
US10894787B2 (en) 2010-09-22 2021-01-19 Arena Pharmaceuticals, Inc. Modulators of the GPR119 receptor and the treatment of disorders related thereto
US11007175B2 (en) 2015-01-06 2021-05-18 Arena Pharmaceuticals, Inc. Methods of treating conditions related to the S1P1 receptor
US11534424B2 (en) 2017-02-16 2022-12-27 Arena Pharmaceuticals, Inc. Compounds and methods for treatment of primary biliary cholangitis
US11884626B2 (en) 2015-06-22 2024-01-30 Arena Pharmaceuticals, Inc. Crystalline L-arginine salt of (R)-2-(7-(4-cyclopentyl-3-(trifluoromethyl)benzyloxy)-1,2,3,4-tetrahydrocyclo-penta [b]indol-3-yl)acetic acid(Compound1) for use in S1P1 receptor-associated disorders

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH485753A (de) * 1966-07-28 1970-02-15 Ciba Geigy Verfahren zur Herstellung neuer Aminopyrimidine
MXPA05007614A (es) * 2003-02-24 2006-05-25 Arena Pharm Inc Derivados de fenilo y piridilpiperidina como moduladores del metabolismo de glucosa.
DE602005011279D1 (de) * 2004-06-04 2009-01-08 Arena Pharm Inc Substituierte aryl- und heteroarylderivate als modulatoren des stoffwechsels und für die prophylaxe und behandlung von damit in zusammenhang stehenden erkrankungen
GT200500284A (es) * 2004-10-15 2006-03-27 Aventis Pharma Inc Pirimidinas como antagonistas del receptor de prostaglandina d2
GEP20104966B (en) * 2005-09-16 2010-04-26 Arena Pharm Inc Modulators of metabolism and the treatment of disorders related thereto
TW200811140A (en) * 2006-07-06 2008-03-01 Arena Pharm Inc Modulators of metabolism and the treatment of disorders related thereto
TW200811147A (en) * 2006-07-06 2008-03-01 Arena Pharm Inc Modulators of metabolism and the treatment of disorders related thereto
EP3378854B1 (en) 2010-01-27 2022-12-21 Arena Pharmaceuticals, Inc. Processes for the preparation of (r)-2-(7-(4-cyclopentyl-3-(trifluoromethyl)benzyloxy)-1,2,3,4-tetrahydrocyclopenta[b]indol-3-yl)acetic acid and salts thereof

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB944443A (US07223432-20070529-C00017.png) * 1959-09-25 1900-01-01

Cited By (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8293751B2 (en) 2003-01-14 2012-10-23 Arena Pharmaceuticals, Inc. 1,2,3-trisubstituted aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto such as diabetes and hyperglycemia
US8933083B2 (en) 2003-01-14 2015-01-13 Arena Pharmaceuticals, Inc. 1,2,3-trisubstituted aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto such as diabetes and hyperglycemia
US7470699B2 (en) 2003-07-11 2008-12-30 Arena Pharmaceuticals, Inc. Trisubstituted aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto
US7838525B2 (en) 2003-07-11 2010-11-23 Arena Pharmaceuticals, Inc. Trisubstituted aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto
US8546429B2 (en) 2003-07-11 2013-10-01 Arena Pharmaceuticals, Inc. 1,2,3-trisubstituted aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto
US7812159B2 (en) 2005-01-10 2010-10-12 Arena Pharamaceuticals, Inc. Processes for preparing aromatic ethers
US8362248B2 (en) 2005-01-10 2013-01-29 Arena Pharmaceuticals, Inc. Substituted pyridinyl and pyrimidinyl derivatives as modulators of metabolism and the treatment of disorders related thereto
US10894787B2 (en) 2010-09-22 2021-01-19 Arena Pharmaceuticals, Inc. Modulators of the GPR119 receptor and the treatment of disorders related thereto
US11007175B2 (en) 2015-01-06 2021-05-18 Arena Pharmaceuticals, Inc. Methods of treating conditions related to the S1P1 receptor
US11884626B2 (en) 2015-06-22 2024-01-30 Arena Pharmaceuticals, Inc. Crystalline L-arginine salt of (R)-2-(7-(4-cyclopentyl-3-(trifluoromethyl)benzyloxy)-1,2,3,4-tetrahydrocyclo-penta [b]indol-3-yl)acetic acid(Compound1) for use in S1P1 receptor-associated disorders
US11534424B2 (en) 2017-02-16 2022-12-27 Arena Pharmaceuticals, Inc. Compounds and methods for treatment of primary biliary cholangitis

Also Published As

Publication number Publication date
SU436494A3 (ru) 1974-07-15
FR6084M (US07223432-20070529-C00017.png) 1968-06-04
CH478818A (de) 1969-09-30
CH499528A (de) 1970-11-30
SE345273B (US07223432-20070529-C00017.png) 1972-05-23
IL26473A (en) 1971-08-25
CH478817A (de) 1969-09-30
FR6083M (US07223432-20070529-C00017.png) 1968-06-04
FR1500479A (fr) 1967-11-03
SU427513A3 (ru) 1974-05-05
CH478816A (de) 1969-09-30
CH478819A (de) 1969-09-30
BE688660A (US07223432-20070529-C00017.png) 1967-04-21
BR6683919D0 (pt) 1973-12-04
DE1670392A1 (de) 1970-07-16
GB1135259A (en) 1968-12-04
US3503963A (en) 1970-03-31

Similar Documents

Publication Publication Date Title
JPS4321924Y1 (US07223432-20070529-C00017.png)
JPS4414139Y1 (US07223432-20070529-C00017.png)
JPS4217625Y1 (US07223432-20070529-C00017.png)
JPS432835Y1 (US07223432-20070529-C00017.png)
JPS456767Y1 (US07223432-20070529-C00017.png)
JPS4322324Y1 (US07223432-20070529-C00017.png)
JPS435041Y1 (US07223432-20070529-C00017.png)
AU6340065A (US07223432-20070529-C00017.png)
BE675041A (US07223432-20070529-C00017.png)
BE667905A (US07223432-20070529-C00017.png)
NL6600562A (US07223432-20070529-C00017.png)
NL6502447A (US07223432-20070529-C00017.png)
LU52148A1 (US07223432-20070529-C00017.png)
NL6613403A (US07223432-20070529-C00017.png)
NL6617424A (US07223432-20070529-C00017.png)
BE667329A (US07223432-20070529-C00017.png)
BE666089A (US07223432-20070529-C00017.png)
BE663881A (US07223432-20070529-C00017.png)
BE660387A (US07223432-20070529-C00017.png)
BE657982A (US07223432-20070529-C00017.png)
BE667396A (US07223432-20070529-C00017.png)
BE689409A (US07223432-20070529-C00017.png)
BE683730A (US07223432-20070529-C00017.png)
BE675750A (US07223432-20070529-C00017.png)
BE675195A (US07223432-20070529-C00017.png)